Abstract:Allergen exposure chamber (AEC) challenge effectively evaluates timothy grass allergy in rhinitis patients. Symptom severity reproducibly correlates with timothy grass pollen concentrations. AEC challenge can be plausible for allergy diagnostics and patient stratification in clinical research. AEC, allergen exposure chamber; AR, allergic rhinitis; ARM, acoustic rhinometry; FEV1, forced expiratory volume in the first second; HC, healthy control; p/m3, particles/cubic meter; MCA, minimal cross‐sectional area; PEFR, peak expiratory flow rate; PNIF, peak nasal inspiratory flow; TNSS, total nasal symptom score. Background The fluctuation in concentrations of airborne allergens frequently presents a challenge to assessing the efficacy of allergen immunotherapy (AIT) in 'field' studies. Allergen exposure chambers (AECs) are specialized medical installations developed to expose individuals to allergens at defined and consistent concentrations under a controlled environment. The aim of the study was to validate the provocation test with timothy grass pollen as well as to assess its safety in the AEC in patients with allergic rhinitis. Methods In the ALLEC® AEC, varying concentrations of timothy grass pollen were dispersed. Allergic symptoms were measured by total nasal symptom score (TNSS), acoustic rhinometry, peak nasal inspiratory flow (PNIF) and nasal discharge volume. Lung function, assessed through peak expiratory flow rate (PEFR) and forced expiratory volume in the first second (FEV1), was used to evaluate safety. Results The consistency of the test was proved by the stability of environmental conditions, including temperature, humidity and CO2 levels, as well as constant concentrations of grass pollen at predetermined levels ranging from 1000 to 10,000 particles per cubic meter (p/m3). Allergic individuals developed symptoms at concentrations of 3000 p/m3 and above, across all measured endpoints. Lung function was not affected throughout all the challenges. The reproducibility of symptoms was confirmed throughout the tests. The concentration of 8000 p/m3 together with a challenge duration of 120 min was found to be optimal. Conclusion The study demonstrates that the ALLEC® grass pollen exposure chamber provides a reliable and safe method for inducing repeatable symptoms in patients with allergic rhinitis. This approach can be effectively applied for allergy diagnostics and clinical endpoint determination during AIT.

Standardisation of allergen products: 4. Validation of a candidate European Pharmacopoeia standard method for quantification of major grass pollen allergen Phl p 5

Improved quality control of allergen products: Assessing the molecular allergen composition by mass spectrometry

Standardization and Regulation of Allergen Products in the European Union

Phl p 5 levels more strongly associated than grass pollen counts with allergic respiratory health

Qualitative and quantitative comparison of allergen component-specific to birch and grass analyzed by ImmunoCAP assay and Euroline immunoblot test

Clinical validation of grass pollen exposure chamber in patients with allergic rhinitis triggered by timothy grass

Diagnostic relevance of IgE sensitization profiles to eight recombinant Phleum pratense molecules

Component-resolved diagnosis for phleum allergy: the role of recombinants

Identification and semi-quantification of protein allergens in complex mixtures using proteomic and AllerCatPro 2.0 bioinformatic analyses: a proof-of-concept investigation

Intradermal Phleum pratense allergoid immunotherapy. Double-blind, randomized, placebo-controlled trial

Allergen manufacturing and quality aspects for allergen immunotherapy in Europe and the United States: An analysis from the EAACI AIT Guidelines Project

Erratum: Request to Include COA Number Beta-Expansin of Bermuda, Johnson, and Para grass pollens, is a major cross-reactive allergen for allergic rhinitis patients in subtropical climate

Possible manufacture of test allergens in public pharmacies for the diagnosis of type I allergies: Legal aspects

Measurement of IgE to pollen allergen components is helpful in selecting patients for immunotherapy

Procedure for a standardized preparation of skin prick test solutions for the diagnosis of occupational type I allergies in the absence of commercial extracts

Sensitivity and specificity of standardised allergen extracts in skin prick test for diagnoses of IgE-mediated respiratory allergies

Nanofluidic point-of-care IgE test for subtropical grass pollen for rapid diagnosis of allergic rhinitis

The skin prick test – European standards

Development of incurred chocolate bars and broth powder with six fully characterised food allergens as test materials for food allergen analysis

Detection and Quantitation of Selected Food Allergens by Liquid Chromatography with Tandem Mass Spectrometry: First Action 2017.17

Physicochemical and immunological characterization of Amb a 12, a novel ragweed (Ambrosia artemisiifolia) pollen allergen